Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06617715 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 28, 2026 (before its estimated May 12, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Oct 12, 2025 to May 12, 2026
    • Study completion date: Apr 12, 2026 to Jul 30, 2026
    v5
  2. Primary completion date: Mar 12, 2025 to Oct 12, 2025
    • Enrollment target: 3975 to 3080
    • Study description shortened, about 17 words
    • Eligibility criteria shortened, about 2 words
    v4
  3. Study title shortened, about 2 wordsv3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 12, 2024 to Oct 23, 2024
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Phase Ⅲ clinical trial of 13-valent pneumococcal conjugate vaccine (PCV13) developed by Sinovac Life Science Co., Ltd will be conducted in pediatric population aged 2 months (minimum 6 weeks)-5 years (before 6th birthday). The objective of the study is to evaluate the immunogenicity and safety of Sinovac PCV13.
Trial Details
NCT Number NCT06617715
Lead Sponsor Sinovac Life Sciences Co., Ltd.
Conditions
(from sponsor)		 Pneumococcal Infectious Disease
Related terms Pneumococcal Infections
Enrollment 3,080 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov